Evidence map›Paper›PMID 24367694›Full record

ArticlePloS one2013

Deficient beta-mannosylation of Candida albicans phospholipomannan affects the proinflammatory response in macrophages.

Audrey Devillers, Flavie Courjol, Chantal Fradin, Agnes Coste, Daniel Poulain, Bernard Pipy, Emerson Soares Bernardes, Thierry Jouault

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Fungal glycans and the innate immune recognition.Frontiers in cellular and infection microbiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Audrey DevillersInserm U995, Team 2, Lille, France ; Université Lille Nord de France, Lille, France ; Université Droit et Santé Lille2, Lille, France.
Flavie CourjolInserm U995, Team 2, Lille, France ; Université Lille Nord de France, Lille, France ; Université Droit et Santé Lille2, Lille, France.
Chantal FradinInserm U995, Team 2, Lille, France ; Université Lille Nord de France, Lille, France ; Université Droit et Santé Lille2, Lille, France.
Agnes CosteUnité Mixte de Recherche MD3, EA2405 Polarisation des macrophages et recepteurs nucleaires dans les pathologies inflammatoires et infectieuses, Université Paul Sabatier, Toulouse, France ; Unité mixte de recherche 152, Université Paul Sabatier, Toulouse, France.
Daniel PoulainInserm U995, Team 2, Lille, France ; Université Lille Nord de France, Lille, France ; Université Droit et Santé Lille2, Lille, France.
Bernard PipyUnité Mixte de Recherche MD3, EA2405 Polarisation des macrophages et recepteurs nucleaires dans les pathologies inflammatoires et infectieuses, Université Paul Sabatier, Toulouse, France ; Unité mixte de recherche 152, Université Paul Sabatier, Toulouse, France.
Emerson Soares BernardesCancer Institute of the State of São Paulo, São Paulo, Brazil.
Thierry JouaultInserm U995, Team 2, Lille, France ; Université Lille Nord de France, Lille, France ; Université Droit et Santé Lille2, Lille, France.
Université Lille Nord de France · FRUniversité Toulouse III - Paul Sabatier · FRInserm · FRInstituto do Câncer do Estado de São Paulo · BRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans produces a complex glycosphingolipid called phospholipomannan (PLM), which is present on the cell-wall surface of yeast and shed upon contact with host cells. The glycan moiety of PLM is composed of β-mannosides with degrees of polymerization up to 19 in C. albicans serotype A. PLM from serotype B strains displays a twofold decrease in the length of the glycan chains. In this study we compared the proinflammatory activities of PLMs purified from C. albicans serotype A and serotype B strains and from a bmt6Δ mutant of C. albicans, whose PLM is composed of short truncated oligomannosidic chain. We found that PLMs activate caspase-1 in murine macrophage cell line J774 independent of the glycan chain length although IL-1β secretion is more intense with long glycan chain. None of the tested PLMs stimulate ROS production, indicating that caspase-1 activation may occur through a ROS-independent pathway. On the other hand, only long-chain oligomannosides present on PLM from serotype A strain (PLM-A) are able to induce TNF-α production in macrophages, a property that is not affect by blocking endocytosis through latrunculin A treatment. Finally, we demonstrate that soluble and not cell surface-bound galectin-3, is able to potentiate PLM-A-induced TNF-α production in macrophages. PLMs from C. albicans serotype B and from bmt6∆ mutant are not able to induce TNF-α production and galectin-3 pretreatment does not interfere with this result. In conclusion, we show here that PLMs are able to evoke a proinflammatory state in macrophage, which is in part dependent on their glycosylation status. Long-glycan chains favor interaction with soluble galectin-3 and help amplify inflammatory response.

Indexed as

Analysis of VarianceAnimalsbeta-MannosidaseBlotting, WesternCandida albicansCaspase 1Cell LineElectrophoresisGalectin 3GlycolipidsInflammationMacrophagesMicePolymerizationReactive Oxygen SpeciesSpecies Specificitybeta-MannosidaseCaspase 1Galectin 3GlycolipidsphospholipomannanReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID24367694
PMCPMC3868656
OpenAlexW1973650836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.